Rafał Dolot

This paper demonstrates that B-ASOLNA-CHOL, a boron cluster-conjugated antisense oligonucleotide, enhances cancer cell uptake and cytotoxicity when combined with radiotherapy, reducing tumor size in xenograft models.

This study develops HINT1 inhibitors to explore their effects on MOR-NMDAR cross-regulation and analgesia, showing selective modulation of pain pathways without affecting opioid tolerance.